ENDPOINTS

CRISPR startup Arbor Biotechnologies raises $73.9M as it nears first trial

Arbor Biotechnologies, a startup founded by CRISPR pioneer Feng Zhang nine years ago, has closed a $73.9 million Series C financing to bring its first therapy into clinical trials — a treatment that could help prevent ...

Mar 18, 2025 - 11:30
 0
CRISPR startup Arbor Biotechnologies raises $73.9M as it nears first trial
Arbor Biotechnologies, a startup founded by CRISPR pioneer Feng Zhang nine years ago, has closed a $73.9 million Series C financing to bring its first therapy into clinical trials — a treatment that could help prevent ...
Read More

Tags:

Previous Article

Bringing the Heat: Abigail Howard Leads Thermal Systems for Artemis Rovers, Tools

Next Article

Space debris is falling from the skies. We need to tackle this growing danger

Related Posts

ITM reports more Phase 3 radiopharma data in challenge to Novartis’ Lutathera

ITM reports more Phase 3 radiopharma data in challenge ...

Mar 6, 2025  0

Exclusive: CRISPR delivery startup Spotlight Therapeutics shuts down

Exclusive: CRISPR delivery startup Spotlight Therapeuti...

Feb 19, 2025  0

Merck opens billion-dollar facility to make bladder cancer immunotherapy

Merck opens billion-dollar facility to make bladder can...

Mar 11, 2025  0